Curcumin Promotes Apoptosis of Activated Hepatic Stellate Cells by Inhibiting Protein Expression of the MyD88 Pathway

Abstract

Activation and proliferation of hepatic stellate cells (HSC) play an important role in the progress of liver fibrosis. HSC activation occurs in response to inflammatory cytokines, cellular interactions with immune cells, and morphogenetic signals. The literature hints to a role of the adaptor protein MyD88 in fibrosis. Although curcumin has been shown to exert inhibitory effects on the proliferation of HSC in vitro, its influence on the MyD88 pathway in HSC has remained unclear. Here, we investigated whether curcumin accelerates apoptosis of HSC through the MyD88 pathway. HSC (rat HSC T6) were divided into a control group, MyD88 small interfering RNA (siRNA) group, curcumin group, and curcumin + MyD88 siRNA group. The MyD88 siRNA groups were exposed to siRNA for 48 h. The curcumin groups were cultured in the presence of curcumin for 24 h. Apoptosis was detected by flow cytometry. For Toll-like receptor (TLR) 2 and 4 as well as MyD88 and the dependent factors NF-κB, TNF-α, and IL-1β, mRNA expression was detected by reverse transcription polymerase chain reaction (RT-PCR). For MyD88, protein expression was further observed by Western Blot. Both curcumin and MyD88 siRNA inhibited the mRNA expression of MyD88 pathway-related effectors (TLR2, TLR4, NF-κB, TNF-α, IL-1β) in HSC. Furthermore, both treatments reduced the expression of MyD88 protein in HSC and promoted their apoptosis. These effects were more obvious in the curcumin + MyD88 siRNA group. This study demonstrates that curcumin promotes apoptosis of activated HSC by inhibiting the expression of cytokines related to the MyD88 pathway. It elucidates the possible mechanisms of curcumin in inducing apoptosis of HSC through the MyD88 pathway.

Key words

Curcuma longa - Zingiberaceae - curcumin - MyD88 - hepatic stellate cells - apoptosis - liver fibrosis

• References

• 1 Reeves HL, Friedman SL. Activation of hepatic stellate cells – a key issue in liver fibrosis. Front Biosci 2002; 7: 808-826
• 2 Spruss A, Kanuri G, Wagnerberger S, Haub S, Bischoff SC, Bergheim I. Toll-like receptor 4 is involved in the development of fructose induced hepatic steatosis in mice. Hepatology 2009; 50: 1094-1104
• 3 Paik YH, Schwabe RF, Bataller R, Russo MP, Jobin C, Brenner DA. Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells. Hepatology 2003; 37: 1043-1055
• 4 Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell 2010; 140: 805-820
• 5 Premkumar V, Dey M, Dorn R, Raskin I. MyD88-dependent and independent pathways of Toll-Like Receptors are engaged in biological activity of triptolide in ligand-stimulated macrophages. BMC Chem Biol 2010; 10: 3
• 6 Seki E, Brenner DA. Toll-like receptors and adaptor molecules in liver disease: update. Hepatology 2008; 48: 322-335
• 7 Crane M, Visvanathan K, Lewin SR. HIV infection and TLR signalling in the liver. Gastroenterol Res Pract 2012; 2012: 473925
• 8 Shu JC, He YJ, Lv X, Zhao JR, Zhao J, Shen Y, Ye GR, Wang LX. Effect of curcumin on the proliferation and apoptosis of hepatic stellate cells. Braz J Med Biol Res 2009; 42: 1173-1178
• 9 Vizzutti F, Provenzano A, Galastri S, Milani S, Delogu W, Novo E, Caligiuri A, Zamara E, Arena U, Laffi G, Parola M, Pinzani M, Marra F. Curcumin limits the fibrogenic evolution of experimental steatohepatitis. Lab Invest 2009; 90: 104-115
• 10 He YJ, Kuchta K, Lv X, Lin Y, Ye GR, Liu XY, Song HD, Wang LX, Kobayashi Y, Shu JC. Curcumin, the main active constituent of turmeric (Curcuma longa L.), induces apoptosis in hepatic stellate cells by modulating the abundance of apoptosis-related growth factors. Z Naturforsch C 2015; 70: 281-285
• 11 Shu JC, Kuchta K, He YJ, Deng YM, Lin Y, Ye GR, Lv X, Liu XY, Kobayashi Y. Curcumin induces apoptosis in hepatic stellate cells via inhibition of the MyD88 pathway. Planta Med 2015; 81: PW_67
• 12 Kiso Y, Suzuki Y, Watanabe N, Oshima Y, Hikino H. Antihepatotoxic principles of Curcuma longa rhizomes. Planta Med 1983; 49: 185-187
• 13 Tang Y. Curcumin targets multiple pathways to halt hepatic stellate cell activation. Updated mechanisms in vitro and in vivo . Dig Dis Sci 2015; 60: 1554-1564
• 14 Lin YL, Lin CY, Chi CW, Huang YT. Study on antifibrotic effects of curcumin in rat hepatic stellate cells. Phytother Res 2009; 23: 927-932
• 15 Yao QY, Xu BL, Wang JY, Liu HC, Zhang SC, Tu CT. Inhibition by curcumin of multiple sites of the transforming growth factor-beta1 signalling pathway ameliorates the progression of liver fibrosis induced by carbon tetrachloride in rats. BMC Complement Altern Med 2012; 12: 156-166
• 16 Shu JC, He YJ, Lv X, Ye GR, Wang LX. Curcumin prevents liver fibrosis by inducing apoptosis and suppressing activation of hepatic stellate cells. J Nat Med 2009; 63: 415-420
• 17 Lukita-Atmadja W, Ito Y, Baker GL, McCuskey RS. Effect of curcuminoids as anti-inflammatory agents on the hepatic microvascular response to endotoxin. Shock 2002; 17: 399-403